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Nonhuman primate neuroimaging is on the cusp of a transformation, much in the same way its human coun-
terpart was in 2010, when the Human Connectome Project was launched to accelerate progress. Inspired by
an open data-sharing initiative, the global community recently met and, in this article, breaks through
obstacles to define its ambitions.Nonhuman primate (NHP) neuroimaging
carries tremendous translational promise
for biomedicine (Phillips et al., 2014;
Roelfsema and Treue, 2014). However,
progress has been slow, as researchers
face not only the many challenges that
human neuroimaging has overcome but
also unique obstacles that require
consensus solutions. To date, the
approach has remained largely piecemeal
and single-lab driven, causing most
NHP researchers to struggle to amass
datasets consisting of even 10 to 20 sub-
jects, whereas their human-imaging
counterparts now aim for thousands.
The PRIMatE Data Exchange (PRIME-
DE) was recently established to accel-
erate the pace of advancement (Milham
et al., 2018) by promoting a culture of
collaboration and open science in the
NHP neuroimaging community. PRIME-
DE established a repository of openly
shared data in 2018, followed by a Global
Collaboration Workshop (GCW) on
September 5–6, 2019 at the Wellcome
Trust in London. Through these efforts,
the community has made substantial
progress toward a global vision and here
outlines its ambitious albeit eminently
achievable goals. Four key domains of
activity in NHP neuroimaging are consid-
ered that can dramatically accelerate
progress.
Standardizing Data Collection
Harmonizing Data Collection Is Key
for Reproducibility and Shared
Data Value
Minimal Data Acquisition Specifications.
There was agreement that a universal
data acquisition protocol is not yet prac-
tical, but minimal specifications can be
defined toward standardization. A shared600 Neuron 105, February 19, 2020 ª 2019 Elesson from the Human Connectome
Project (Van Essen et al., 2013) is that
the cortical sheet should be resolvable
with isotropic voxels no larger than half
the minimum cortical thickness (e.g.,
0.5–0.6 mm voxels for macaque cortex
and 0.4 mm for marmosets). Acquiring
3D T1- and T2-weighted scans is impor-
tant for brain segmentation, and T1/T2
ratios can generate ‘‘myelin maps’’ to
assist surface mapping and rapid quality
checking.
For functional MRI, attainable target
spatial resolutions are 1.0-mm isotropic
voxels for large NHPs and 0.5 mm for
smaller ones. However, these are beyond
the 1.2–1.5 mm range currently employed
on common 3 Tesla scanners, and
manufacturers are phasing out gradient
inserts previously used to boost signal-
to-noise. A way forward is the adoption
of more sophisticated coil systems with
higher signal to noise (SNR), enhanced
with acceleration methods (multiband im-
aging) for higher functional and temporal
resolution with less acquisition time.
These coils are commercially available
(24-channel macaque, 16-channel
marmoset) though still require customiza-
tion to accommodate head posts and/or
chambers.
Anesthetized Imaging. Although
awake imaging is clearly the long-term
aspiration for NHP imaging, it is techni-
cally challenging and requires training
the subject. Thus, anesthetized imaging
remains important for resting-state,
diffusion, and structural imaging and
benefits from minimal head motion. A
key factor for establishing common
practice is standardizing the anesthetic
agents. Many GCW laboratories
already use highly similar protocols,lsevier Inc.entailing isoflurane anesthesia for
structural imaging and IV administration
of dexmedetomidine (0.015–0.02mg per
kg bolus or 4.5–5.0ug per kg per h infu-
sion) to allow reduction of isoflurane
concentrations to between 0.6%–1.0%
to improve the functional MRI signal.
Other agents are being successfully
employed and might be required by
researchers for scientific reasons (Fleck-
nell, 2015). Beyond the specific agents
employed, opportunities exist to
advance the monitoring and control of
anesthesia depth throughout scanning
by logging temperature, end tidal CO2,
O2 saturation, respiration rate, heart
rate, and blood pressure synchronized
to data acquisition.
Awake Imaging. Four identifiable chal-
lenges confront awake NHP imaging.
First is the challenge of behavioral
training for the scanner environment.
Second, the placement of head immobi-
lization hardware determines which
brain areas are accessible with head
coils. This precludes universal accep-
tance of a single head coil and necessi-
tates customization or generating a
range of standardized options. Third,
noninvasive eye tracking provides a
key control measure in awake NHPs.
Finally, head and jaw movements, as
well as the apparent head movement
and brain distortions produced by
changes in susceptibility from body
and limb motion, remain a problem for
awake imaging, particularly at high
magnetic fields. Behavioral training and
external monitoring methods, such as
magnetic resonance (MR)-compatible
video tracking and jaw and/or body
motion sensors, can be invaluable
for correcting motion. Post-acquisition
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will help; and film viewing, when appro-
priate, can decrease head motion (as re-
ported in human neuroimaging).
Opportunities for Improving Data
Quality. Although using higher field
scanners is an obvious way to improve
data quality, current costs (1 million
USD per Tesla) and operational nuances
make them relatively inaccessible to
most groups. Recent findings suggest
that iron-based contrast agents such
as monocrystalline iron oxide nanopar-
ticle (MION) can increase contrast-to-
noise ratio (CNR) and spatial specificity
at 3 T. However, this has limitations, as
the agents tend to be costly, and
frequent usage necessitates the intro-
duction of chelating agents to minimize
impact on animal welfare by long-term
accumulation of iron. Additionally,
contrast agents measure cerebral blood
volume (CBV) rather than the blood-
oxygenation-level-dependent (BOLD)
response, complicating comparison to
human BOLD fMRI. Unlike human MRI,
NHP MRI suffers from dramatic signal
variations from coils or other sources.
Thus, appropriate quality control strate-
gies should be implemented both for
custom and standard coils. An approach
to improve fMRI data quality is to in-
crease the number and duration of
acquisition sessions (Xu et al., 2018).
Prospective motion correction ap-
proaches deployed in human research
(Maclaren et al., 2013) may also improve
structural imaging. Currently, the main
way to avoid motion artifacts in awake
imaging is to limit head movements
(e.g., training or head immobilizing).
Finally, investigators identified the
need for creating and sharing NHP
‘‘phantoms,’’ which would allow data-
collection sites to check and benchmark
their data-collection protocols using
a common reference as is done in hu-
man imaging. Such phantoms would
be created and made freely available
as a 3D-printed model of a given spe-
cies’ brain filled with a contrast agent
with known relaxation times to stan-
dardize signal-to-noise assessment
across sites. Phantoms could be
created for any of the primate species
(apes, marmosets, baboons, ma-
caques). Importantly, working on good
quality data acquisition beats anypost-acquisition cleaning algorithm
available and is crucial if we are to
create standard pipelines for NHP MRI
data analysis.
Animal Welfare, Regulations, and
Intellectual Property
NHP Imaging Stakeholders Are
Seeking Policy-Making Guidance
from and Working with Funding
Agencies, Professional Societies,
and the Larger Community to
Ensure Maximum Benefit and
Transparency
Animal Welfare and Regulations. NHP
neuroscience is a heavily scrutinized and
extremely sensitive area of research with
extensive ethical approval processes
and oversight. However, NHP research
is not governed by a common set of inter-
national regulations or ethical statements
(e.g., Declaration of Helsinki for human
research). National differences in NHP
research and NHP welfare regulations
are particularly problematic for efforts to
collaborate internationally. The commu-
nity agreed that addressing this challenge
going forward will benefit from additional
transparency when sharing their datasets,
including identification of the relevant
regulatory body and reference to their
published standards. Additionally, it will
be important to increase the collection
and sharing alongside MRI data of objec-
tive and evidence-based measures of an-
imal health status as metadata, which can
also provide scientific insights (e.g.,
home-cage behavioral data, eye-tracking
data, genomic information, rearing and
maintenance information, sourcing of
animals, anesthesia maintenance values,
as relevant). National primate centers
and breeding sites can help with collec-
tion of this metadata.
Engaging the Public. Candid and trans-
parent communication with the public on
the importance of nonhuman animal
research is vital for maintaining and
increasing governmental and public sup-
port. It is not uncommon for institutions
and scientists to find themselves in a
reactive rather than proactive position,
focusing solely on the defense of their
work. Recent experience is showing that
a proactive stance raises public aware-
ness and support for animal research as
a key element of modern science and
medicine, balancing the discussion ofconcerns raised by activist groups. Politi-
cians are often unaware of the impact of
the animal research occurring in their
own constituencies, which can lead to
legislation being put forward that fails to
capture the importance of scientific ad-
vances. Institutional and funding-body
press offices could better link transla-
tional developments directly to the foun-
dational research performed on labora-
tory animals because the reporting of the
fundamental animal research bases is
often unmentioned. Researchers and
their institutions can find support and
public-engagement training from groups
such as Speaking of Research (US),
Basel Declaration on Animal Research
(EU), Pro-Test Deutschland (GER), Pro-
Test Italia (ITL), Understanding Animal
Research (UK), and Gircor (FRA).
Alongside the importance of the work,
the public can learn about the balance
between benefits and harms, including
evidence-based safeguards for animal
welfare. Several institutions have
now signed the UK Concordat on
Openness in Animal Research (http://
concordatopenness.org.uk). This now
five-year-old agreement, currently signed
by 122 institutions, encourages openness
and better information sharing about
animal research. Rather than being a
generic statement on openness that will
find nominal support by most institutions,
the Concordat annually assesses, sup-
ports, and rewards institutional public
engagement efforts. Communication ef-
forts emerging from signatories of this
agreement have been impressive (more
useful information on institutional web-
sites, patient-led activities, virtual tours
of animal facilities, and better-balanced
social media discussions). Lastly, the
community noted the need for increased
leadership from the national and interna-
tional research organizations in efforts to
explain the continued importance of
NHP research, supporting researchers
and engaging the public.
Crediting and Intellectual Property. In
NHP research, where substantial costs
and efforts are required for training or
maintenance of a single individual, investi-
gators hold real concerns about not being
appropriately credited or being ‘‘scooped’’
analytically with one’s own data. Recent
years have witnessed an increasing
acceptance of ‘‘data descriptors’’ orNeuron 105, February 19, 2020 601
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structures (Neuroimaging Informatics
Tools and Resources Clearinghouse
[NITRC], Zenodo) as a publication-based
means of crediting data generators and
encouraging sharing. Digital object identi-
fiers (DOI) assigned to datasets can further
assure the rapid identification, crediting,
and tracking of datasets. However, such
efforts need to be recognized by the insti-
tutions and used in promotion reviews
(e.g., Declaration on Research Assess-
ment, https://sfdora.org). This situation is
problematic for the advancement of open
science andmust be addressed by a coor-
dinated effort involving both institutions
and funders recognizing the importance
of data generation and sharing. These real-
ities often drive investigators to hold back
their newest data from sharing initiatives,
instead sharing only those datasets that
have already yielded publications.
GCWparticipants converged on a solu-
tion that moving forward, in addition to
fully open sharing options, a ‘‘collabora-
tion seeking’’ sharing option will be added
with the following terms: (1) early sharing
encouraged, but an investigator can
accept or reject access requests to
these data; (2) the investigative team
may receive co-authorship credit on the
publication (to be negotiated by the
dataset holders and proposed collabo-
rator); and (3) upon publication of the
first manuscript, the data status will
switch to open sharing. Additionally,
GCW participants felt that the generation
of a registry of ongoing studies would
be immensely important for the NHP
research community to avoid duplicating
efforts and to foster collaboration.
Finally, the issue of using shared data for
commercial purposes remains unre-
solved. In human studies, the data gener-
ators can consent to commercial use or
not, but for the NHP community, it is
less clear if ownership lies with the data




The Adoption of Data Standards and
Open Analytic Solutions Are Readily
Attainable
Data Standards. There is a clear need
for metadata standards in NHP data
acquisition. The Brain Imaging Data602 Neuron 105, February 19, 2020Structure (BIDS) framework (Gorgolewski
et al., 2016), used in the initial PRIME-
DE data release, is recommended given
its rapid maturation and widespread
adoption in human neuroimaging,
including EEG and MEG. However, the
BIDS format will require revision to cap-
ture the range of metadata unique to
NHPs. Minimally, species and scanning
position (upright, sphinx) require specifi-
cation. Metadata could also include de-
tails regarding anesthesia protocol,
contrast agents, coil type (surface versus
volume), head-fixation information, sub-
species, age, sex, universal specimen
identifiers, body weight, available
genomic information, and animal origin.
The NIfTI (Neuroimaging Informatics
Technology Initiative) and GIfTI (geometry
format under NIfTI) formats, for volumetric
and surface datasets respectively, pro-
vide a standard for porting data between
software packages. The CIFTI (Connec-
tivity Informatics Technology Initiative)
format appears to be well positioned as
a framework for connectivity analyses
that span surface-based representations
and subcortical regions.
Quality Assessment.NHP imagers have
yet to reach a consensus on quality
assessment or assurance. Some datasets
might be of higher quality, even if these
are from fewer animals. There are also
concerns that implementing high QC
standards at this initial stage will stall
data sharing, and analytic methods
may be developed to rescue lower
quality data. In the human literature,
steps toward universal approaches to
quantify data quality are being made
(e.g., MRIQC) and could be adapted for
NHP imaging. However, most existing
tools are optimized for human heads,
which have very different tissue profiles
and are imaged at lower resolution. Inves-
tigators are leveraging technical ad-
vances (e.g., multichannel segmentation,
deep learning, improved templates) to
break through this barrier and avoid
manual correction. However, at present,
visual inspection and ratings remain key
steps for quality assessment and analyt-
ical validation. Given these realities, the
PRIME-DE consortium has recommen-
ded sharing all data regardless of data
quality and to share QC ratings for the
datasets. Finally, real-time quality assess-
ments have been recently automated inthe human literature (e.g., the Framewise
Integrated Real-time MRI Monitoring
[FIRMM]) and could be adapted for NHP
imaging for motion monitoring, feedback,
and to assess when sufficient data have
been collected.
Pipelines. There is a scarcity of end-to-
end NHP image preprocessing pipeline
solutions, including surface-based ana-
lyses. Investigators identified a range of
open-source tools and pipelines that are
available or progressing in their develop-
ment, making it just a matter of time
until the reliance on in-house code de-
creases. This process can be accelerated
through establishing mechanisms for
rapid communication of developments
via wikis, mailing lists, technical notes,
code repositories, notebooking sites,
and Brainhack events. Such communica-
tion is especially important in assisting
investigators from outside of NHP imag-
ing to engage with this community’s
data. Publication of methods papers is
encouraged and their value should be
considered in assessing a researcher’s
productivity. Lastly, it is worth noting
that scientists are making progress in
tackling the challenges of within and
interspecies alignment. These efforts
are crucial not only in advancing our
understanding of the NHP brain but also
in creating a common terminology be-
tween researchers from human imaging
and the NHP community who quite
often still use different vocabularies. A
critical ongoing effort by some groups
attending the GCW is the alignment of
imaging and digitization of the wealth of
histological and tract-tracing data in
NHPs. With sufficient investment, such
important data could be curated, helping
to bridge analytical scales.
Coordinated Paradigm Design
Common Ground in Functional
Imaging Creates Opportunities for
Globally Coordinated Activity
Functional localizers are commonly used
in human and NHP imaging, spanning
retinotopy, tonotopy, object perception,
somatotopy, eye movements, social
cognition, and more. To date, labs have
tended to use customized approaches
by creating and using their own localizer
stimuli, typically in a relatively limited
number of subjects. Commonalities in
focus areas across laboratories create
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design and data sharing. First, the simple
sharing of final statistical maps (e.g., via
NeuroVault, Open Science Framework,
or the Brain Analysis Library of Spatial
Maps and Atlases [BALSA]) would gener-
ously allow applying meta-analytic tech-
niques and aggregating across site infor-
mation. Equally important, the sharing of
functional localizer stimuli would allow
harmonizing efforts and, as a result,
improve the likelihood of reproducible
findings, dramatically enhancing the value
of shared datasets. Complementing
lower-level functional localizers are natu-
ralistic stimuli (e.g., films), which can be
used to probe a range of systems,
including higher-order association areas.
Unfortunately, there is great variation in
naturalistic stimuli across laboratories
and in custom analyses that are needed
to extract meaningful information from
these localizers. As a first step, the com-
munity agreed that small groups will
work together on obtaining coordinated
localizer data for different modalities in
30 individuals as a basis for creating tem-
plate-based probabilistic maps. These
data will be invaluable to the broader
community that often requires information
on where functional fiducials reside in
specific individuals. Long term, the com-
munity wants to work toward generating
a collection of natural films and analytical
approaches for a rapid (10–15 min) multi-
faceted ‘‘primate global localizer’’ that
could be used by many laboratories. Its
usefulness will need to be validated and
established alongside information from
accepted localizers.
Ambitions for the Next Five Years
Over the course of the next five to ten
years, the PRIME-DE GCW attendees
agreed that it will be possible to collect
and share structural scans from 1,000
NHPs in various species with further
grassroots sharing efforts of higher quality
and more extensive datasets in 200 ani-
mals. With financial support, the coordi-nation of activities centered around local-
izers could yield data from 30 animals
for a given localizer, as the community
works toward a multi-faceted primate
functional localizer. More substantial in-
vestment would allow the generation of
a large-scale, multimodal resource for
NHPs similar to the Human Connectome
Project, possibly including developmental
samples (pediatric, fetal) and metadata
(genotyping and phenotyping information,
etc.). The integration of digitized neuronal
tract tracing data, neurophysiology (high
density recordings, laminar, etc.), histol-
ogy, and neuromodulation approaches
(optogenetics, electrical microstimula-
tion, pharmacological inactivation, ultra-
sound, etc.) would bring unprecedented
value to the resource.Conclusion
We have synthesized a perspective put
forward by the GCWmeeting on the chal-
lenges and opportunities for NHP imaging
and the ambitions of the community.
Given the grassroots nature of the effort,
the community recognized the need to
meet regularly to strengthen communica-
tion and facilitate progress. Following the
lead of its human counterpart, NHP imag-
ing is unquestionably evolving toward
reproducible and scalable science. To
accelerate the pace of its evolution
through increased collaboration, sharing,
and investment, large-scale global neuro-
science ventures (e.g., the BRAIN Initia-
tive, Human Brain Project) and other fund-
ing schemes will need to support the
community objectives for the next five to
ten years of data generation and sharing.
If the PRIME-DE GCW serves as a litmus
test, exciting advances, and discoveries
will become evident by global collabora-
tion and support.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at
https://doi.org/10.1016/j.neuron.2019.12.023.ACKNOWLEDGMENTS
Facilities and event support for the The PRIMateE
(PRIME-DE) Data Exchange Global Collaboration
Workshop were provided by the Wellcome Trust.
Administrative and logistical support for the GCW
and the Brainhack immediately following the event
were provided by the Child Mind Institute, as well
as the National Institute of Mental Health
(P50MH109429). Travel stipends for early career
investigators were made possible through the
generous support of the BRAIN Initiative
(R24MH114806), Kavli Foundation, and Well-
come Trust.REFERENCES
Flecknell, P. (2015). Laboratory Animal
Anaesthesia (Academic Press).
Gorgolewski, K.J., Auer, T., Calhoun, V.D.,
Craddock, R.C., Das, S., Duff, E.P., Flandin, G.,
Ghosh, S.S., Glatard, T., Halchenko, Y.O., et al.
(2016). The brain imaging data structure, a format
for organizing and describing outputs of neuroi-
maging experiments. Sci. Data 3, 160044.
Maclaren, J., Herbst, M., Speck, O., and Zaitsev,
M. (2013). Prospective motion correction in brain
imaging: a review. Magn. Reson. Med. 69,
621–636.
Milham, M.P., Ai, L., Koo, B., Xu, T., Amiez, C.,
Balezeau, F., Baxter, M.G., Blezer, E.L.A.,
Brochier, T., Chen, A., et al. (2018). An Open
Resource for Non-human Primate Imaging.
Neuron 100, 61–74.e2.
Phillips, K.A., Bales, K.L., Capitanio, J.P., Conley,
A., Czoty, P.W., ’t Hart, B.A., Hopkins, W.D., Hu,
S.-L., Miller, L.A., Nader, M.A., et al. (2014). Why
primate models matter. Am. J. Primatol. 76,
801–827.
Roelfsema, P.R., and Treue, S. (2014). Basic
neuroscience research with nonhuman primates:
a small but indispensable component of biomed-
ical research. Neuron 82, 1200–1204.
Understanding Animal Research. Concordat on
Openness on Animal Research in the UK. http://
concordatopenness.org.uk.
Van Essen, D.C., Smith, S.M., Barch, D.M.,
Behrens, T.E., Yacoub, E., and Ugurbil, K.; WU-
Minn HCP Consortium (2013). The WU-Minn
Human Connectome Project: an overview.
Neuroimage 80, 62–79.
Xu, T., Falchier, A., Sullivan, E.L., Linn, G., Ramirez,
J.S.B., Ross, D., Feczko, E., Opitz, A., Bagley, J.,
Sturgeon, D., et al. (2018). Delineating the
Macroscale Areal Organization of the Macaque
Cortex In Vivo. Cell Rep. 23, 429–441.Neuron 105, February 19, 2020 603
Neuron, Volume 105Supplemental InformationAccelerating the Evolution
of Nonhuman Primate Neuroimaging




The PRIMatE Data Exchange (PRIME-DE) Global Collaboration Workshop and 
Consortium 
Michael Milham1,2, Christopher I. Petkov3, Daniel S. Margulies4, Charles E. Schroeder2,5, 
Michele A. Basso6, Pascal Belin7, Damien A. Fair8, Andrew Fox9,10, Sabine Kastner11, Rogier B. 
Mars12,13, Adam Messinger14, Colline Poirier3, Wim Vanduffel15,16,17, David C. Van Essen18, 
Ashkan Alvand19, Yannick Becker20, Suliann Ben Hamed21, Austin Benn22, Clementine Bodin7, 
Susann Boretius23, Bastien Cagna7, Olivier Coulon7, Sherif Hamdy El-Gohary24, Henry 
Evrard2,25,26, Stephanie J. Forkel27, Patrick Friedrich28,29, Sean Froudist-Walsh30, Eduardo A. 
Garza- Villarreal31, Yang Gao32, Alessandro Gozzi33, Antoine Grigis34, Renee Hartig26, Takuya 
Hayashi35, Katja Heuer36, Henrietta Howells37, Dirk Jan Ardesch38, Béchir Jarraya39,40, Wendy 
Jarrett41, Hank P. Jedema42, Igor Kagan23, Clare Kelly43, Henry Kennedy44,45,46, P. Christiaan 
Klink47, Sze Chai Kwok48,49,50, Robert Leech51, Xiaojin Liu52,53, Christopher Madan54, Wasana 
Madushanka55, Piotr Majka56, Ann-Marie Mallon57, Kevin Marche12, Adrien Meguerditchian20,58, 
Ravi S. Menon59, Hugo Merchant31, Anna Mitchell12, Karl-Heinz Nenning60, Aki Nikolaidis1, 
Michael Ortiz-Rios3, Marco Pagani33, Vikas Pareek61, Mark Prescott62, Emmanuel Procyk44, 
Reza Rajimehr63, Ioana-Sabina Rautu64,65, Amir Raz66,67, Anna Wang Roe32,68, Román Rossi-
Pool69, Lea Roumazeilles12, Tomoko Sakai70, Jerome Sallet12, Pamela García-Saldivar31, Chika 
Sato70, Stephen Sawiak63, Marike Schiffer71, Caspar M. Schwiedrzik23,72, Jakob Seidlitz14,63, 
Julien Sein7, Zhi-ming Shen73, Amir Shmuel74, Afonso C. Silva75, Luciano Simone37, Nikoloz 
Sirmpilatze23, Julia Sliwa76, Jonathan Smallwood77, Jordy Tasserie39,40, Michel Thiebaut de 
Schotten78, Roberto Toro79, Regis Trapeau7, Lynn Uhrig39,40, Julien Vezoli80, Zheng Wang45,46, 
Sara Wells81, Bella Williams41, Ting Xu1, Augix Guohua Xu32, Essa Yacoub82, Ming Zhan14, Lei 
Ai1, Céline Amiez44, Fabien Balezeau3, Mark G. Baxter83, Erwin L.A. Blezer84, Thomas Brochier7, 
Aihua Chen85, Paula L. Croxson83, Christienne G. Damatac86, Stanislas Dehaene34, Stefan 
Everling87, Lazar Fleysher83, Winrich Freiwald88, Timothy D. Griffiths3, Carole Guedj89, Fadila 
Hadj-Bouziane89, Noam Harel82, Bassem Hiba21, Benjamin Jung14, Bonhwang Koo1, Kevin N. 
Laland90, David A. Leopold14, Patrik Lindenfors91,92, Martine Meunier89, Kelvin Mok74, John H. 
Morrison9,10, Jennifer Nacef3, Jamie Nagy83, Mark Pinsk11, Simon M. Reader93,94, Pieter R. 
Roelfsema47, David A. Rudko74, Matthew F.S. Rushworth95, Brian E. Russ14, Michael C. 
Schmid3, Elinor L. Sullivan68,96, Alexander Thiele3, Orlin S. Todorov97, Doris Tsao98, Leslie 
Ungerleider14, Charles R.E. Wilson44, Frank Q. Ye14, Wilbert Zarco88 and Yong-di Zhou99,100.  
 
1. Child Mind Institute, 101 E 56th St, New York, NY 10022, USA 
2. Nathan Kline Institute, 140 Old Orangeburg Rd, Orangeburg, NY 10962, USA 
3. Newcastle University, Newcastle upon Tyne NE1 7RU, UK 
4. Centre National de la Recherche Scientifique (CNRS), 3, rue Michel-Ange, Paris 16, 
France 
5. Columbia University, 116th St & Broadway, New York, NY 10027, USA 
6. University of California, Los Angeles, Los Angeles, CA 90095 USA 
7. Institut de Neurosciences de la Timone, UMR 7289, CNRS and Aix-Marseille University, 
Faculté de Médecine, 27 Boulevard Jean Moulin, 13005 Marseille, France 
8. Department of Behavior Neuroscience, Department of Psychiatry, Advanced Imaging 
Research Center, Oregon Health and Science University, Portland, OR, USA. 
9. California National Primate Research Center, University of California, Davis, Davis, CA 
95616 USA 
10. University of California, Davis, Davis, CA 95616 USA 
11. Princeton Neuroscience Institute, Princeton University, Princeton, NJ 08540, USA. 
12. Oxford University, Oxford OX1 2JD, UK 
13. Radboud University Nijmegen, Montessorilaan 3, 6525 HR Nijmegen, The Netherlands 
14. National Institute of Mental Health, Bethesda, MD 20892, USA. 
15. Laboratory for Neuro- and Psychophysiology, Neurosciences Department, KU Leuven 
Medical School, 3000 Leuven, Belgium 
16. Harvard Medical School, Boston, Massachusetts, 02115, USA. 
17. Massachusetts General Hospital, Martinos Ctr. for Biomedical Imaging, Charlestown, 
Massachusetts 02129, USA. 
18. Washington University in St Louis, 1 Brookings Dr, St. Louis, MO 63130, USA 
19. University of Auckland, Auckland CBD, Auckland 1010, New Zealand 
20. Laboratoire de Psychologie Cognitive UMR 7290, Aix-Marseille Univ, CNRS, 13331, 
Marseille, France. 
21. Institut des Sciences Cognitives Marc Jeannerod, Lyon, France 
22. Centro Nacional Investigaciones Cardiovascular, Calle de Melchor Fernández Almagro, 
3, 28029 Madrid, Spain 
23. German Primate Center – Leibniz Institute for Primate Research, Kellnerweg 4, 37077 
Göttingen, Germany 
24. Cairo University, Al Orman، Giza Governorate 12613, Egypt 
25. Max Planck Institute for Biological Cybernetics, Tübingen, Germany 
26. Centre for Integrative Neuroscience, Otfried-Müller-Str. 25, 72076 Tübingen, Germany 
27. King's College London, Institute of Psychiatry Psychology and Neuroscience, 
Department of Neuroimaging, London UK 
28. Brain Connectivity and Behaviour Laboratory (BCBLab), Sorbonne Universities, Paris, 
France 
29. ICM Institute for Brain and Spinal Cord, Hôpital Pitié Salpêtrière, 47 Boulevard de 
l'Hôpital, 75013 Paris, France 
30. New York University, New York, NY 10003, USA 
31. Institute of Neurobiology (INB), National Autonomous University of Mexico (UNAM), 
Campus Juriquilla, UNAM Boulevard Juriquilla 3001, 76230 Santiago de Querétaro, 
Qro., Mexico 
32. Interdisciplinary Institute of Neuroscience and Technology, School of Medicine, Zhejiang 
University, Hangzhou 310029, China 
33. Istituto Italiano di Tecnologia, Corso Bettini 31, 38068, Rovereto, Italy 
34. Neurospin, Bâtiment 145, Point Courrier 156, CEA-Saclay Center, F91191 Gif-sur-
Yvette Cedex, France 
35. RIKEN Center for Biosystems Dynamics Research, 6-7-3 Minatojima-minamimachi, 
Chuo-ku, Kobe, Hyogo 650-0047, Japan 
36. Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany 
37. University of Milan, Humanitas Research Hospital, Via Alessandro Manzoni 56, 20089, 
Milano MI, Italy 
38. Vrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV Amsterdam, Netherlands 
39. Cognitive Neuroimaging Unit, Institut National de la Santé et de la Recherche Médicale 
U992, Gif-sur-Yvette, France 
40. Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Direction de la 
Recherche Fondamentale, NeuroSpin Center, Gif-sur-Yvette, France  
41. Understanding Animal Research, Abbey House, 74-76 St John Street, London EC1M 
4DZ, UK 
42. IRP-National Institute on Drug Abuse, NIH, Baltimore, MD, USA 
43. Trinity College Dublin, College Green, Dublin 2, Ireland 
44. University of Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain 
Research Institute U1208, 69500 Bron, France. 
45. Institute of Neuroscience, Center for Excellence in Brain Science and Intelligence 
Technology, Chinese Academy of Sciences, Shanghai 200031, China 
46. Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, 
Shanghai 200031, China. 
47. Netherlands Institute for Neuroscience, Meibergdreef 47, 1105 BA Amsterdam-Zuidoost, 
Netherlands. 
48. Shanghai Key Laboratory of Brain Functional Genomics, Key Laboratory of Brain 
Functional Genomics Ministry of Education, School of Psychology and Cognitive 
Science, East China Normal University, Shanghai, China 
49. Shanghai Key Laboratory of Magnetic Resonance, East China Normal University, 
Shanghai, China 
50. NYU-ECNU Institute of Brain and Cognitive Science at NYU Shanghai, Shanghai, China 
51. King's College London, Strand, London WC2R 2LS, UK 
52. Institute of Neuroscience and Medicine (INM-7, Brain and Behaviour), Research Centre 
Jülich, Jülich, Germany 
53. Institute of Systems Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf, 
Germany 
54. University of Nottingham, Nottingham NG7 2RD, UK 
55. Tianjin Medical University, Tianjin, China 
56. Laboratory of Neuroinformatics, Nencki Institute of Experimental Biology, Warsaw, 
Poland 
57. MRC Harwell Institute, Harwell Campus, Oxfordshire, OX11 0RD, UK 
58. Station de Primatologie UPS 846, CNRS, 13790, Rousset, France 
59. Western University, 1151 Richmond St, London, ON N6A 3K7, Canada 
60. Medical University of Vienna, Spitalgasse 23, 1090 Wien, Austria 
61. National Neuroimaging Facility, Computational Neuroscience & Neuroimaging, 
Department, National Brain Research Center, Manesar, Haryana, 122052, India 
62. National Centre for the Replacement Refinement and Reduction of Animals in Research 
(NC3Rs) Gibbs Building, 215 Euston Road, London, NW1 2BE, UK 
63. University of Cambridge, The Old Schools, Trinity Ln, Cambridge CB2 1TN, UK 
64. Technical University of Munich, Arcisstraße 21, 80333 München, Germany 
65. University of Regensburg, Universitätsstraße 31, 93053 Regensburg, Germany 
66. Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montréal, QC H3T 
1E2, Canada 
67. McGill University, 845 Sherbrooke St W, Montreal, Quebec H3A 0G4, Canada 
68. Division of Neuroscience, Oregon National Primate Research Center (ONPRC), Oregon 
Health & Science University, Beaverton, OR  97006, USA 
69. Instituto de Fisiología Celular─Neurociencias, Universidad Nacional Autónoma de 
México, 04510 Mexico City, Mexico 
70. National Institute of Radiological Sciences, 4 Chome-9-1 Anagawa, Inage Ward, Chiba, 
263-8555, Japan 
71. Nature Human Behaviour, The Campus, 4 Crinan Street, London N1 9XW, UK 
72. European Neuroscience Institute, a Joint Initiative of the of the University Medical Center 
Göttingen and the Max Planck Society, Grisebachstraße 5, 37077 Göttingen, Germany 
73. Chinese Academy of Sciences, Neuroscience Institute, 320 Yueyang Road, Shanghai, 
200031 
74. Montreal Neurological Institute, McGill University, 3801 University St., Montreal, QC H3A 
2B4, Canada 
75. University of Pittsburgh, Department of Neurobiology, 3501 Fifth Avenue, 6065 BST3, 
Pittsburgh, PA, 15261 USA 
76. Institut du Cerveau et de la Moelle épinière, CNRS UMR7225, Sorbonne Université 
UMRS1127, Inserm U1127, Paris, France 
77. University of York, Heslington, York YO10 5DD, UK 
78. Groupe d’Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives-UMR 
5293, CNRS, CEA University of Bordeaux, Bordeaux, France 
79. Institut Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France 
80. Ernst Strüngmann Institute, Deutschordenstraße 46, 60528 Frankfurt am Main, Germany 
81. Centre for Macaques (CFM), MRC Harwell Institute, Porton Down, Salisbury, SP4 0JQ 
82. Center for Magnetic Resonance Research, University of Minnesota Medical School, 
Minneapolis, MN 55455, USA. 
83. Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 
10029, USA. 
84. Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University 
Medical Center Utrecht, Utrecht, The Netherlands. 
85. Key Laboratory of Brain Functional Genomics (Ministry of Education & Science and 
Technology Commission of Shanghai Municipality), School of Life Sciences, East China 
Normal University, Shanghai 200062, China. 
86. Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen, 6525 
EN Nijmegen, Netherlands. 
87. Centre for Functional and Metabolic Mapping, The University of Western Ontario, 
London, ON N6A 3K7, Canada. 
88. Laboratory of Neural Systems, The Rockefeller University, New York, NY, USA. 
89. Lyon Neuroscience Research Center, ImpAct Team, INSERM U1028, CNRS UMR5292, 
Université Lyon 1, Bron, France 
90. Centre for Social Learning and Cognitive Evolution, School of Biology, University of St. 
Andrews, St. Andrews, UK. 
91. Institute for Future Studies, Stockholm, Sweden. 
92. Centre for Cultural Evolution & Department of Zoology, Stockholm University, 
Stockholm, Sweden. 
93. Department of Biology and Helmholtz Institute, Utrecht University, 3584 CH Utrecht, The 
Netherlands 
94. Department of Biology, McGill University, Montreal, QC H3A 1BA, Canada 
95. Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford OX1 3AQ, 
UK. 
96. Department of Human Physiology, University of Oregon, Eugene, OR, USA. 
97. School of Biological Sciences, The University of Queensland, St. Lucia, Queensland 
4072, Australia  
98. Department of Computation and Neural Systems, California Institute of Technology, 
Pasadena, CA 91125, USA. 
99. Krieger Mind/Brain Institute, Department of Neurosurgery, Johns Hopkins University, 
Baltimore, MD 21287, USA. 
100. School of Psychology, Shenzhen University, Shenzhen, China
